Deep Track Capital, LP 13D and 13G filings for Maze Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 08:48 am Purchase | 2025-06-30 | 13G | Maze Therapeutics, Inc. MAZE | Deep Track Capital, LP | 3,948,910 9.020% | 925,426 (+30.61%) | Filing |
| 2025-02-07 4:30 pm Purchase | 2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE | Deep Track Capital, LP | 3,023,484 6.910% | 3,023,484 (New Position) | Filing |